Zhejiang Orient Gene Biotech Co., Ltd.

Shanghai Stock Exchange 688298.SS

Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2023: 201,819,084

Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) is 201,819,084 for the year ending December 31, 2023, a 20.15% change year over year. Shares (diluted, weighted) are the number of outstanding shares used to calculate earnings per share (EPS) assuming the conversion of all potentially dilutive securities.

Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2022 was 167,970,295, a 16.64% change year over year.
Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2021 was 144,005,507, a -27.03% change year over year.
Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2020 was 197,336,322, a 30.19% change year over year.
Zhejiang Orient Gene Biotech Co., Ltd. Shares (Diluted, Weighted) for the year ending December 31, 2019 was 151,578,805, a 0.76% change year over year.

Key data

Date	Shares (Diluted, Weighted)	Revenue	Cost of Revenue	Gross Profit

Shanghai Stock Exchange: 688298.SS

Zhejiang Orient Gene Biotech Co., Ltd.

CEO	Mr. Xiaoliang Fang
IPO Date	Feb. 5, 2020
Location	China
Headquarters	3787#, East Yangguang Avenue
Employees	2,231
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Zhejiang Orient Gene Biotech Co., Ltd. researches and develops, produces, and sells colloidal gold tests, urinalysis strips, raw materials, instruments, and molecular diagnosis products primarily in China. Its products include genetic diagnosis products; colloidal gold rapid diagnostic tests for drugs of abuse, infectious diseases, fertility, cardiac and tumor markers, and autoimmunity; dry chemical strips; bio-liquid diagnostic kits; clinical test instruments; POCT time-resolved fluor immunoassay test kits; raw materials; etc. The company also exports its products to North and South America, Europe, South Asia, Southeast Asia, the Middle East, Africa, Russia, and Australia. Zhejiang Orient Gene Biotech Co., Ltd. was founded in 2005 and is based in Huzhou, China.

Key trends

Past 5 years